StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · CELZ·Healthcare

Creative Medical Technology Holdings, Inc. Stock Analysis & AI Score

Creative Medical Technology Holdings, Inc. (CELZ) has an ST Score of 43.6 (C), driven by its Financial Strength (A+) and held back by its Momentum (F). Analysts rate it Buy.

Market Closed
$0.97
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
44
ST Score
43.6/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

CELZ
43.6out of 100
Grade C

Creative Medical Technology Holdings, Inc. (CELZ) has an ST Score of 43.6 (C), driven by its Financial Strength (A+) and held back by its Momentum (F). Analysts rate it Buy.

Strongest
Financial StrengthA+
Weakest
MomentumF
All factor grades
  • Financial StrengthA+
  • GrowthA+
  • ValuationC
  • ProfitabilityD+
  • MomentumF
  • Piotroski1/9
Score methodology
Press Releases

Contact

CELZ stock: frequently asked questions

What is CELZ's ST Score?

Creative Medical Technology Holdings, Inc. (CELZ) has an ST Score of 43.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is CELZ a buy, hold, or sell?

Analysts rate CELZ a Buy. Our ST Score grades it C (43.6/100). The ST Score is a data-driven signal, not a recommendation.

What are CELZ's factor grades?

Valuation C, Profitability D+, Financial Strength A+, Momentum F, Growth A+.

What is CELZ's valuation grade?

Creative Medical Technology Holdings, Inc. (CELZ) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is CELZ's growth grade?

Creative Medical Technology Holdings, Inc. (CELZ) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is CELZ's profitability grade?

Creative Medical Technology Holdings, Inc. (CELZ) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is CELZ's financial strength grade?

Creative Medical Technology Holdings, Inc. (CELZ) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is CELZ's Piotroski score?

Creative Medical Technology Holdings, Inc. (CELZ) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.